L26/P-187 High oocyte survival after fast warming across multiple cryo-devices in donor oocyte cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C. Tanner und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Can vitrified oocytes be warmed using a fast-warming protocol across different cryo-devices while maintaining high survival immediately and 24 hours post-warming? Summary answer Fast warming resulted in high oocyte survival immediately and at 24 hours post warming, independent of cryo-device used. What is known already Oocyte vitrification is a technically demanding and time-intensive laboratory procedure. Advances in cryo-device design, as well as vitrification and warming protocols, have prompted reassessment of practices that optimize oocyte survival. Most available data are derived from donor oocytes, which represent a best-case population; however, accumulating feasibility data in this setting provides an important foundation before broader clinical application, including use with autologous oocytes. Study design, size, duration This prospective study was conducted from April 2025 to December 2025. Excess donor oocytes from a donor program were included. A total of 180 oocytes were randomly allocated and vitrified across three cryo-devices. Survival was assessed immediately post-warming and at 24 hours. Statistical analysis was performed using chi-square testing with α = 0.05. Participants/materials, setting, methods Donor oocytes from a private IVF center were included. All vitrification and warming procedures were performed by a single embryologist using Vit-NX and Warm-NX media. Cryo-devices evaluated were Cryolock-S (Group 1), cryoGO (Group 2), and Cryotop Flash (Group 3). Vitrification followed a standard 13-minute protocol, and warming utilized a fast 1-minute Thaw Solution-only protocol. Post-warming, oocytes were placed in low-lactate culture medium for 24-hour assessment. Main results and the role of chance Overall immediate post-warming survival across all groups was 100.0%. Mean time to oocyte release from the device was 7.1 ± 2.2 seconds and did not differ between groups. Survival rates by device were 91.7% (Group 1), 93.3% (Group 2), and 95.0% (Group 3), with no significant differences observed (p = 0.751) at 24 hours. 24-hour survival by maturation stage (MII, MI, GV) was 93.3%, 90.3%, and 100.0%, respectively (p = 0.182), with no significant differences within or between cryo-device groups. Limitations, reasons for caution As a pilot study, a larger sample size is required to confirm these findings and assess downstream clinical outcomes, including fertilization and embryo development. Evaluation using autologous oocytes across a wide age range would better reflect routine clinical practice. Wider implications of the findings This data demonstrates that oocytes across all maturation stages can be successfully warmed using a fast, 1-minute Thaw Solution-only protocol across multiple cryo-devices. Adoption of streamlined warming approaches may improve laboratory efficiency while maintaining excellent oocyte survival, pending confirmation of clinical outcomes. Trial registration number No
Zitieren
APA
Tanner, C., Brewer, A., Guerrero, C., Moffitt, D., & VerMilyea, L. (2026). L26/P-187 High oocyte survival after fast warming across multiple cryo-devices in donor oocyte cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.523
Vancouver
Tanner C, Brewer A, Guerrero C, Moffitt D, VerMilyea L. L26/P-187 High oocyte survival after fast warming across multiple cryo-devices in donor oocyte cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.523
BibTeX
@article{Tanner2026,
author = {Tanner, C. and Brewer, A. and Guerrero, C. and Moffitt, D. and VerMilyea, L.},
title = {L26/P-187 High oocyte survival after fast warming across multiple cryo-devices in donor oocyte cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.523}
}
EUVIMED